According to 89bio's latest financial reports the company's current EPS (TTM) is -HK$16.40. In 2022 the company made an earnings per share (EPS) of -HK$27.52 an increase over its 2021 EPS that were of -HK$34.83.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$16.54 | -39.9% |
2022 | -HK$27.52 | -20.98% |
2021 | -HK$34.83 | 44.52% |
2020 | -HK$24.10 | -62.95% |
2019 | -HK$65.05 |